Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study

被引:1
作者
Gao, Shengqiang [1 ]
Ramen, Kuvaneshan [2 ]
Yu, Shian [1 ]
Luo, Jiansheng [1 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Sch Med, Dept Hepatobiliary & Pancreat Surg, Jinhua 321000, Zhejiang, Peoples R China
[2] Dept Hepatobiliary & Pancreat Surg, Vacoas Phoenix, Mauritius
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2020年 / 13卷 / 10期
关键词
Non-HDLc/HDLc ratio; prospective study; fatty liver disease; NAFLD; STEATOHEPATITIS; POPULATION; PREVALENCE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-high-density lipoprotein cholesterol (non-HDLc) to HDLc ratio (non-HDLc/HDLc), is a viable predictor of metabolic syndrome, insulin resistance, and other cardiac diseases. The study aimed to assess whether non-HDLC/HDLc ratio is an independent predictor of NAFLD. Methods: The present study was a longitudinal study, involving 16173 Chinese men and women, aging 14-95 years old, who received a medical check-up program in a health examination Center in China. A total of 16173 initially NAFLD-free non-obese individuals were included, who completed a 5-year follow-up examination in the longitudinal study. NAFLD was defined by ultrasonographic detection of steatosis in the absence of other liver disease. Univariate and multivariate Cox proportional hazards analyses were used to assess the association between nonHDLC/HDLc and NAFLD. ROC curve analysis was performed to compare the predictive value between the nonHDLc/HDLc and the nonHDLc for NAFLD. Results: During the five-year follow-up period, a total of 2322 participants (14.4%) developed NAFLD. The HRs for NAFLD in the longitudinal population were 1.3 (95% CI 1.1 to 1.7) and 1.5 (95% CI 1.1 to 2.0) compared with Q1. AUC values for nonHDLc/HDLc ratios (0.705) were significantly higher than nonHDLc (0.656) (P<0.05), while the cut-off value for the detection of NAFLD was 2.26. Individuals with higher nonHDLc/HDLc ratio had an increased cumulative incidence rate of NAFLD in non-obese individuals. Conclusion: The Non-HDLc ratio/HDLc is an independent predictor of NAFLD. This may help with early identification of high-risk individuals.
引用
收藏
页码:2569 / 2575
页数:7
相关论文
共 23 条
  • [1] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [2] Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
    DeFilippis, Andrew Paul
    Blaha, Michael J.
    Martin, Seth S.
    Reed, Robert M.
    Jones, Steven R.
    Nasir, Khurram
    Blumenthal, Roger S.
    Budoff, Matthew J.
    [J]. ATHEROSCLEROSIS, 2013, 227 (02) : 429 - 436
  • [3] The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease
    Ducheix, Simon
    Montagner, Alexandra
    Theodorou, Vassilia
    Ferrier, Laurent
    Guillou, Herve
    [J]. BIOCHEMICAL PHARMACOLOGY, 2013, 86 (01) : 96 - 105
  • [4] The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA)
    Foster, Temitope
    Anania, Frank A.
    Li, Dong
    Katz, Ronit
    Budoff, Matthew
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (08) : 2392 - 2398
  • [5] Dysfunctional Very-Low-Density Lipoprotein Synthesis and Release Is a Key Factor in Nonalcoholic Steatohepatitis Pathogenesis
    Fujita, Koji
    Nozaki, Yuichi
    Wada, Koichiro
    Yoneda, Masato
    Fujimoto, Yoko
    Fujitake, Mihoyo
    Endo, Hiroki
    Takahashi, Hirokazu
    Inamori, Masahiko
    Kobayashi, Noritoshi
    Kirikoshi, Hiroyuki
    Kubota, Kensuke
    Saito, Satoru
    Nakajima, Atsushi
    [J]. HEPATOLOGY, 2009, 50 (03) : 772 - 780
  • [6] Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
    Kimura, Yuki
    Hyogo, Hideyuki
    Yamagishi, Sho-ichi
    Takeuchi, Masayoshi
    Ishitobi, Tomokazu
    Nabeshima, Yoshitaka
    Arihiro, Koji
    Chayama, Kazuaki
    [J]. JOURNAL OF GASTROENTEROLOGY, 2010, 45 (07) : 750 - 757
  • [7] Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
    Kistler, Kristin D.
    Brunt, Elizabeth M.
    Clark, Jeanne M.
    Diehl, Anna Mae
    Sallis, James F.
    Schwimmer, Jeffrey B.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (03) : 460 - 468
  • [8] Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: The ARIC Study
    Lamprea-Montealegre, Julio A.
    Sharrett, A. Richey
    Matsushita, Kunihiro
    Selvin, Elizabeth
    Szklo, Moyses
    Astor, Brad C.
    [J]. ATHEROSCLEROSIS, 2014, 234 (01) : 42 - 46
  • [9] The global NAFLD epidemic
    Loomba, Rohit
    Sanyal, Arun J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (11) : 686 - 690
  • [10] Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes - The Strong Heart Study
    Lu, WQ
    Resnick, HE
    Jablonski, KA
    Jones, KL
    Jain, AK
    Howard, WJ
    Robbins, DC
    Howard, BV
    [J]. DIABETES CARE, 2003, 26 (01) : 16 - 23